Models

Dataset Information

0

Eftimie2017/1 - interaction of Th and macrophage


ABSTRACT: The paper describes a model of interaction of Th cells and macrophage in melanoma. Created by COPASI 4.25 (Build 207) This model is described in the article: Modelling and investigation of the CD4 T cells – Macrophages paradox in melanoma immunotherapies Raluca Eftimie, Haneen Hamam Journal of Theoretical Biology 420 (2017) 82–104 Abstract: It is generally accepted that tumour cells can be eliminated by M1 anti-tumour macrophages and CD8+ T cells. However, experimental results over the past 10–15 years have shown that B16 mouse melanoma cells can be eliminated by the CD4+ T cells alone (either Th1 or Th2 sub-types), in the absence of CD8+ T cells. In some studies, elimination of B16 melanoma was associated with a Th1 immune response (i.e., elimination occurred in the presence of cytokines produced by Th1 cells), while in other studies melanoma elimination was associated with a Th2 immune response (i.e., elimination occurred in the presence of cytokines produced by Th2 cells). Moreover, macrophages have been shown to be present inside the tumours, during both Th1 and Th2 immune responses. To investigate the possible biological mechanisms behind these apparently contradictory results, we develop a class of mathematical models for the dynamics of Th1 and Th2 cells, and M1 and M2 macrophages in the presence/absence of tumour cells. Using this mathematical model, we show that depending on the re- polarisation rates between M1 and M2 macrophages, we obtain tumour elimination in the presence of a type-I immune response (i.e., more Th1 and M1 cells, compared to the Th2 and M2 cells), or in the presence of a type- II immune response (i.e., more Th2 and M2 cells). Moreover, tumour elimination is also possible in the presence of a mixed type-I/type-II immune response. Tumour growth always occurs in the presence of a type-II immune response, as observed experimentally. Finally, tumour dormancy is the result of a delicate balance between the pro-tumour effects of M2 cells and the anti-tumour effects of M1 and Th1 cells. To cite BioModels Database, please use: BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models . To the extent possible under law, all copyright and related or neighbouring rights to this encoded model have been dedicated to the public domain worldwide. Please refer to CC0 Public Domain Dedication for more information.

SUBMITTER: Jinghao Men  

PROVIDER: BIOMD0000000770 | BioModels | 2024-09-02

REPOSITORIES: BioModels

Dataset's files

Source:
Action DRS
BIOMD0000000770?filename=Eftimie2017:1.cps Other
BIOMD0000000770?filename=Eftimie2017:1.sedml Other
BIOMD0000000770?filename=Eftimie2017:1.xml Xml
Items per page:
1 - 3 of 3
altmetric image

Publications

Modelling and investigation of the CD4<sup>+</sup> T cells - Macrophages paradox in melanoma immunotherapies.

Eftimie Raluca R   Hamam Haneen H  

Journal of theoretical biology 20170220


It is generally accepted that tumour cells can be eliminated by M1 anti-tumour macrophages and CD8<sup>+</sup> T cells. However, experimental results over the past 10-15 years have shown that B16 mouse melanoma cells can be eliminated by the CD4<sup>+</sup> T cells alone (either Th1 or Th2 sub-types), in the absence of CD8<sup>+</sup> T cells. In some studies, elimination of B16 melanoma was associated with a Th1 immune response (i.e., elimination occurred in the presence of cytokines produced b  ...[more]

Similar Datasets

2024-09-02 | BIOMD0000000769 | BioModels
2024-09-02 | BIOMD0000000759 | BioModels
2024-09-02 | BIOMD0000000806 | BioModels
2024-09-02 | BIOMD0000000768 | BioModels
2024-09-02 | BIOMD0000001033 | BioModels
2021-04-29 | PXD023049 | Pride
2024-09-02 | BIOMD0000000810 | BioModels
2023-11-27 | MODEL1909260003 | BioModels
2023-08-29 | PXD044911 | Pride
2005-09-01 | GSE2770 | GEO